A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
Condition(s):Renal Failure , Chronic; AnemiaLast Updated:May 13, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Renal Failure , Chronic; AnemiaLast Updated:May 13, 2013Completed
Condition(s):Subarachnoid HemorrhageLast Updated:July 31, 2018Terminated
Condition(s):Anemia of End Stage Renal DiseaseLast Updated:September 13, 2017Completed
Condition(s):Renal AnemiaLast Updated:November 23, 2022Completed
Condition(s):Anemia; HIV InfectionsLast Updated:May 19, 2011Completed
Condition(s):Renal Insufficiency, ChronicLast Updated:November 3, 2022Completed
Condition(s):Anemia in End-Stage Renal DiseaseLast Updated:December 18, 2019Completed
Condition(s):CancerLast Updated:August 6, 2021Withdrawn
Condition(s):Anemia; Endometrial DiseasesLast Updated:January 23, 2018Completed
Condition(s):Renal AnaemiaLast Updated:October 22, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.